ICICI Lombard General Insurance has scheduled an additional in-person investor engagement with Morgan Stanley analysts in Mumbai for August 28, 2026, expanding its mid-August calendar of institutional interactions. The insurer disclosed the meeting details on July 31, 2026, pursuant to Regulation 30 read with Schedule III and Regulation 46(2) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. This session complements three earlier announced conferences, allowing management to address specific queries from global financial services analysts ahead of the Q2FY27 results cycle.

The Board of Directors authorized this interaction as part of its ongoing investor relations strategy, confirming that no unpublished price-sensitive information will be shared. Vikas Mehra, Company Secretary, signed the intimation letter submitted to both the Bombay Stock Exchange and the National Stock Exchange of India Limited. The disclosure was digitally signed on July 31, 2026, at 13:45:31 IST, ensuring compliance with SEBI’s listing obligations while maintaining transparency with stakeholders.

Updated Meeting Schedule

The company now has four scheduled engagements in August 2026, all held in-person in Mumbai. The updated timeline includes the new Morgan Stanley session alongside previously announced conferences:

All meetings are subject to change due to exigencies on the part of the analysts, investors, or the company. Any modifications will be communicated through subsequent regulatory filings or website updates.

Strategic Context

The addition of a dedicated session with Morgan Stanley’s India Financials Investor Group highlights ICICI Lombard’s focus on engaging with key global institutional players who closely track the insurance sector. While the Nirmal Bang, Emkay, and Motilal Oswal conferences provide broader platforms for discussing sector trends, the Morgan Stanley meeting offers a targeted dialogue with equity analysts specializing in financial services. By holding all engagements in Mumbai, the company minimizes logistical complexity while maximizing accessibility for local and international investors.

What the Numbers Show

Although these filings do not contain financial metrics, the density of investor meetings in late August is significant. It positions management to clarify operational nuances and strategic initiatives following the closure of Q2FY26 and before the release of quarterly results. The preference for in-person interactions over virtual options suggests a desire for nuanced dialogue, potentially indicating that management aims to address complex questions regarding growth strategies or margin trends that may not be fully captured in standard financial statements.

ICICI Lombard General Insurance Company Limited reported a 46% decline in net profit to ₹403.17 crore for the quarter ended June 30, 2026, compared to ₹747.08 crore in the corresponding period of the previous year. The decline was primarily attributed to the recognition of claim reserves amounting to ₹16,500 lakhs following a Supreme Court judgment on June 11, 2026, regarding compensation for unpaid domestic work under the Motor Vehicles Act. Net Premium Written increased by 17.7% to ₹6,603.73 crore from ₹5,610.52 crore in Q1FY26.

Financial Performance

The Board of Directors approved the audited financial results for Q1FY27 on July 15, 2026. The Combined Ratio deteriorated to 107.2% from 102.9% in the previous year. Excluding the impact of the Supreme Court judgment and two large losses in the Fire segment, the company stated that its Profit After Tax (PAT) would have de-grown by 23.0% to ₹5.75 billion. The Solvency Ratio stood at 2.71, slightly improving from 2.70 in the prior year.

The following table summarises the key financial metrics for Q1FY27:

Operational Metrics & Outlook

Looking ahead, the company indicated that the Combined Ratio is expected to improve to 102%-103% in FY27, in line with historical trends. The company noted that the Supreme Court judgment supports the case for a Motor Third-Party Premium hike. The financial results were audited by joint statutory auditors Walker Chandiok & Co LLP and BSR & Co LLP.

Segment Performance

Segment-wise performance varied during the quarter. The Motor segment reported an underwriting loss of ₹2,452.1 crore, while the Health Group, Corporate segment recorded a loss of ₹3,017.3 crore. The Miscellaneous Group, Corporate segment posted a profit of ₹255.9 crore. Retail Health delivered robust growth of 69.5% for Q1FY27 against industry growth of 31.6%.

Corporate Actions

The Board approved a final dividend of ₹7 per equity share of face value ₹10 each for the year ended March 31, 2026. Additionally, the tenure of Mr. Vinod Mahajan, Chief Investment Officer, was extended for two years effective from May 1, 2027, to April 30, 2029.

Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE765G01017/843cbb74-79bc-43cf-bdfc-2aac45d159da.pdf